(Q6)Mar 31, 2024 | (FY)Sep 30, 2023 | (Q9)Jun 30, 2023 | (Q6)Mar 31, 2023 | (Q3)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q9)Jun 30, 2022 | (Q6)Mar 31, 2022 | (Q3)Dec 31, 2021 | (FY)Sep 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 13.48%14.89M | 2.43%46.5M | -6.64%31.03M | -4.66%13.12M | 4.03%7.83M | -21.10%45.4M | -23.57%33.24M | -35.28%13.77M | -43.74%7.52M | -29.81%57.53M |
Operating income | 13.48%14.89M | 2.43%46.5M | -6.64%31.03M | -4.66%13.12M | 4.03%7.83M | -21.10%45.4M | -23.57%33.24M | -35.28%13.77M | -43.74%7.52M | -29.81%57.53M |
Cost of sales | 12.50%-7.19M | -5.46%-23.94M | -1.44%-17.29M | 4.26%-8.22M | 0.59%-4.55M | 18.75%-22.7M | 18.73%-17.04M | 21.37%-8.59M | 27.64%-4.58M | 25.75%-27.94M |
Operating expenses | 12.50%-7.19M | -5.46%-23.94M | -1.44%-17.29M | 4.26%-8.22M | 0.59%-4.55M | 18.75%-22.7M | 18.73%-17.04M | 21.37%-8.59M | 27.64%-4.58M | 25.75%-27.94M |
Gross profit | 57.06%7.7M | -0.60%22.56M | -15.15%13.74M | -5.33%4.9M | 11.21%3.27M | -23.31%22.69M | -28.08%16.19M | -49.96%5.18M | -58.21%2.94M | -33.27%29.59M |
Selling expenses | -37.99%-1.48M | 20.39%-2.6M | 32.14%-1.44M | 31.33%-1.07M | 32.33%-519K | 9.77%-3.27M | -1.77%-2.12M | -31.65%-1.56M | -19.28%-767K | -34.76%-3.63M |
Administrative expenses | 3.46%-11.14M | 2.73%-24.57M | 4.66%-17.72M | 7.68%-11.54M | 11.34%-5.66M | 13.83%-25.26M | 5.09%-18.59M | 2.66%-12.5M | 1.33%-6.38M | 8.24%-29.32M |
Impairment and provision | ---- | ---3.94M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairment is provision | ---- | ---3.94M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Special items of operating profit | 147.67%1.6M | -5.36%1.62M | 77.88%1.11M | 407.09%644K | 682.14%219K | -16.67%1.72M | -45.50%624K | -88.05%127K | -97.30%28K | -21.42%2.06M |
Operating profit | 52.94%-3.32M | -68.05%-6.94M | -10.77%-4.31M | 19.32%-7.06M | 35.73%-2.69M | -218.03%-4.13M | -295.38%-3.89M | -235.02%-8.75M | -531.27%-4.18M | -110.54%-1.3M |
Financing cost | 47.63%-232K | 13.27%-784K | 3.25%-626K | -23.06%-443K | -680.00%-234K | -76.91%-904K | -46.71%-647K | -8.43%-360K | 83.78%-30K | 51.38%-511K |
Earning before tax | 52.62%-3.56M | -53.44%-7.72M | -8.77%-4.94M | 17.64%-7.51M | 30.62%-2.92M | -178.16%-5.03M | -392.65%-4.54M | -209.47%-9.11M | -636.86%-4.21M | -116.06%-1.81M |
Tax | ---- | -98.18%41K | ---- | ---- | ---- | 2,713.75%2.25M | ---- | ---- | ---- | --80K |
After-tax profit from continuing operations | 52.62%-3.56M | -176.16%-7.68M | -8.77%-4.94M | 17.64%-7.51M | 30.62%-2.92M | -60.84%-2.78M | -378.30%-4.54M | -218.12%-9.11M | -636.86%-4.21M | -115.35%-1.73M |
Earning after tax | 52.62%-3.56M | -176.16%-7.68M | -8.77%-4.94M | 17.64%-7.51M | 30.62%-2.92M | -60.84%-2.78M | -378.30%-4.54M | -218.12%-9.11M | -636.86%-4.21M | -115.35%-1.73M |
Profit attributable to shareholders | 52.62%-3.56M | -176.16%-7.68M | -8.77%-4.94M | 17.64%-7.51M | 30.62%-2.92M | -60.84%-2.78M | -378.30%-4.54M | -218.12%-9.11M | -636.86%-4.21M | -115.35%-1.73M |
Basic earnings per share | 52.00%-0.0036 | -175.00%-0.0077 | -8.89%-0.0049 | 17.58%-0.0075 | 30.95%-0.0029 | -264.71%-0.0028 | -381.25%-0.0045 | -213.79%-0.0091 | -625.00%-0.0042 | -84.96%0.0017 |
Diluted earnings per share | 52.00%-0.0036 | -175.00%-0.0077 | -8.89%-0.0049 | 17.58%-0.0075 | 30.95%-0.0029 | -264.71%-0.0028 | -381.25%-0.0045 | -213.79%-0.0091 | -625.00%-0.0042 | -84.96%0.0017 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | Daxin Leung Hok Lian (Hong Kong) Certified Public Accountants Limited | -- | -- | -- | Pang Chi Kwan Certified Public Accountants | -- | -- | -- | Pang Chi Kwan Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data